Cargando…
HGF/c-MET抑制剂治疗非小细胞肺癌的研究进展
Molecular targeted therapy has become more and more important in the treatment of non-small cell lung cancer (NSCLC). HGF/c-MET plays the pivotal role in the growth, development and tolerance to epidermal growth factor receptor tyrosine kinase inhibitor of NSCLC. Moreover it has become another heat...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000280/ https://www.ncbi.nlm.nih.gov/pubmed/25936889 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.09 |